Sharmistha Pal

Employment

• Dr. Reddys Lab Lead-Polymorph Screening
  2021 - Present
• Syngene International (India) Lead Investigator
  2014 - 2020
• AstraZeneca India Pvt. Ltd. Research Scientist
  2009 - 2014
• Eli Lilly & Co. Research Scientist
  2004 - 2008

Education

• University of Minnesota Ph.D.
  1999 - 2004
• Jadavpur University M.Pharm.
  1997 - 1999
• Jadavpur University B.Pharm.
  1993 - 1997

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Mixing Effects on the Ternary Phase Diagram of Cocrystals and Gibbs Formation Energy Calculation
  Crystal Growth & Design 2020 DOI: 10.1021/acs.cgd.0c01077
  +Save
• Crystallization process modifications to address polymorphic and particle size challenges in early stage development of an API salt
  Chemical Engineering Research and Design 2020 DOI: 10.1016/j.cherd.2020.09.021
  +Save
• Solid State Behavior of Impurities during “In-Process” Phase Purity Analysis of an API
  Organic Process Research & Development 2019 DOI: 10.1021/acs.oprd.8b00334
  +Save
• Thermal studies of furosemide–caffeine binary system that forms a cocrystal
  Journal of Thermal Analysis and Calorimetry 2014 DOI: 10.1007/s10973-013-3031-5
  +Save
• High solubility crystalline hydrates of Na and K furosemide salts
  CrystEngComm 2014 DOI: 10.1039/c3ce42347f
  +Save
• Polymorphs and Cocrystals of Nalidixic Acid
  Crystal Growth & Design 2012 DOI: 10.1021/cg300895c
  +Save
• Novel Furosemide Cocrystals and Selection of High Solubility Drug Forms
  Journal of Pharmaceutical Sciences 2012 DOI: 10.1002/jps.22805
  +Save
• Computing the Relative Nucleation Rate of Phenylbutazone and Sulfamerazine in Various Solvents
  Crystal Growth & Design 2005 DOI: 10.1021/cg0342462
  +Save
• Effect of supersaturation on the crystallization of phenylbutazone polymorphs
  Crystal Research and Technology 2005 DOI: 10.1002/crat.200410331
  +Save
• Isostructurality among Five Solvates of Phenylbutazone
  Crystal Growth & Design 2004 DOI: 10.1021/cg049923m
  +Save